Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
04/2003
04/10/2003WO2003029445A1 Process for the production of cells exhibiting an islet-beta-cell-like state
04/10/2003WO2003029444A2 Method and device for extracting secondary plant constituents
04/10/2003WO2003029443A1 Methods of derivation and propagation of undifferentiated human embryonic stem (hes) cells on feeder-free matrices and human feeder layers
04/10/2003WO2003029442A1 Method for production of recombinant proteins in eukaryote cells
04/10/2003WO2003029437A2 Secreted proteins
04/10/2003WO2003029436A2 Ul16 binding protein 4
04/10/2003WO2003029434A2 Novel molecules of the hkid-1-related protein family and uses thereof
04/10/2003WO2003029432A2 Human mesenchymal progenitor cell
04/10/2003WO2003029426A2 Human and murine cytokine polypeptides
04/10/2003WO2003029424A2 Novel proteins and nucleic acids encoding same
04/10/2003WO2003029423A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
04/10/2003WO2003029420A2 Apo-2 ligand variants and uses thereof
04/10/2003WO2003029419A2 Three dimensional structure of crystalline grp94 binding domain, and its methods of use
04/10/2003WO2003029418A2 Proliferation and differentiation of stem cells using extracellular matrix and other molecules
04/10/2003WO2003029417A2 Nutrient medium for maintaining neural cells in injured nervous system
04/10/2003WO2003029413A2 A novel g protein-coupled receptor, gave 10
04/10/2003WO2003029412A2 Restricted expression lentivial vectors
04/10/2003WO2003029407A2 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof
04/10/2003WO2003029402A2 Unique properties of stem cells
04/10/2003WO2003029400A2 Cell lines for productive infection of hepatitis b virus
04/10/2003WO2003029296A1 Human anti-cd40 antibodies
04/10/2003WO2003029295A1 Human tissue factor antibodies
04/10/2003WO2003029293A2 Modulators of notch ic protease activity for use in immunotherapy
04/10/2003WO2003029289A2 Fragements of heat shock proteins and their use
04/10/2003WO2003029288A2 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same
04/10/2003WO2003029286A1 Fluorescent proteins
04/10/2003WO2003029282A2 Tumor-peptide antigens from the human prdi-bf1-protein
04/10/2003WO2003029266A1 Antisense modulation of vascular endothelial growth factor receptor-2 expression
04/10/2003WO2003028757A1 Novel method of inducing antigen-specific t cells
04/10/2003WO2003028651A2 Antipsychotic agents stimulate neurogenesis in brain
04/10/2003WO2003028637A2 Antisense modulation of sphingosine-1-phosphate lyase expression
04/10/2003WO2003028636A2 Antisense modulation of il-1 receptor-associated kinase-4 expression
04/10/2003WO2003028630A2 Methods and compositions for modulating interleukin-21 receptor activity
04/10/2003WO2003028537A2 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
04/10/2003WO2003028536A2 Methods for diagnosing and treating heart disease
04/10/2003WO2003028457A1 Method of restoring ciliated cell motility
04/10/2003WO2003028441A1 Gene therapy for the prevention of autoimmune disease
04/10/2003WO2003017935A9 Human antibodies specific for interleukin 15 (il-15)
04/10/2003WO2003015711A9 Combination motif immune stimulatory oligonucleotides with improved activity
04/10/2003WO2003014326A3 Isolation and mobilization of stem cells expressing vegfr-1
04/10/2003WO2003008575A3 Dna sequences for regulating transcription
04/10/2003WO2003006632A3 Methods and compisitions for activation human t cells in vitro
04/10/2003WO2003006607A9 Inhibition of apoptosis process and improvement of cell performance
04/10/2003WO2003002598A3 Peptides for use as translocation factors
04/10/2003WO2003000114A3 Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis
04/10/2003WO2002101019A3 Methods of culturing animal cells and polypeptide production in animal cells
04/10/2003WO2002100348A8 Human monoclonal antibodies to epidermal growth factor receptor (egfr)
04/10/2003WO2002099087A3 Cell populations for detecting neuronal targets and potential active ingredients
04/10/2003WO2002098365A3 Conditioned cell culture media and uses thereof
04/10/2003WO2002087502A3 Antibodies abolish prion propagation and promote clearance of infectivity
04/10/2003WO2002081668A8 Desaturase genes and uses thereof
04/10/2003WO2002072826A3 Neurotrophic factors
04/10/2003WO2002064756A8 Stem cell identification
04/10/2003WO2002059311A3 Colon cancer marker
04/10/2003WO2002059297A3 A library of a collection of cells
04/10/2003WO2002059290A3 A method for evolving a cell having desired phenotype and envolved cells
04/10/2003WO2002059282A3 Adipocyte complement related protein zacrp13
04/10/2003WO2002059280A3 Chronic lymphocytic leukemia cell line and its use for producing an antibody
04/10/2003WO2002057460A3 Polynucleotides encoding human phosphatases
04/10/2003WO2002055705A3 Proteins and nucleic acids encoding same
04/10/2003WO2002050285A9 Histone deacetylase-related gene and protein
04/10/2003WO2002050122A3 Means for the diagnosis and therapy of ctcl
04/10/2003WO2002050107A3 Streptococcus pyogenes antigens and corresponding dna fragments
04/10/2003WO2002050104A3 Methods and cells for detecting modulators of rgs proteins
04/10/2003WO2002046406A3 Human transporter proteins, nucleic acid molecules encoding them,and uses thereof
04/10/2003WO2002040666A3 Fat regulated genes, uses thereof, and compounds for modulating same
04/10/2003WO2002028889A3 Haemophilus influenzae antigens and corresponding dna fragments
04/10/2003WO2002012477A3 Enhanced replication of hcv rna
04/10/2003WO2002010337A3 Method of cloning porcine animals
04/10/2003WO2002008396A3 Human proteases
04/10/2003WO2002000174A3 Compositions and methods for the therapy and diagnosis of lung cancer
04/10/2003WO2001092547A9 Modified bovine adenovirus having altered tropism
04/10/2003WO2001073014A9 Human survivin interacting protein 1 (sip-1)
04/10/2003WO2001068923A3 Mitochondrial dosimeter
04/10/2003US20030070190 Methods for increasing stearate content in soybean oil
04/10/2003US20030070188 Vanillin biosynthetic pathway enzyme from Vanilla planifolia
04/10/2003US20030070186 Mammalian cells for use as tools in animal cloning
04/10/2003US20030070185 Animal model for use in the generation of preferential antibodies
04/10/2003US20030069409 T1-R ligand III
04/10/2003US20030069407 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030069406 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of blood disorders
04/10/2003US20030069405 70 human secreted proteins
04/10/2003US20030069403 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030069398 Identification of human gaba transporter
04/10/2003US20030069397 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030069394 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030069256 Use of isogenic human cancer cells for high-throughput screening and drug discovery
04/10/2003US20030069223 Peptidyl deformylase inhibitors used for inhibiting bacteria or preventing bacterial contamination of a cell culture medium
04/10/2003US20030069201 Methods of using BCL-2 for the therapeutic treatment and prevention of diseases
04/10/2003US20030069199 Treatment methods based on microcompetition for a limiting GABP complex
04/10/2003US20030069197 Probes and primers can be employed in diagnostic kits, in identifying or isolating mammalian PTTG nucleic acid, and in detecting a pathological mass associated with PTTG expression.
04/10/2003US20030069181 Alternative splice forms of proteins as basis for multiple therapeutic modalities
04/10/2003US20030069179 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030069178 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068820 Hematopoietic stem cell proliferating agents
04/10/2003US20030068819 Differentiation of primate embryonic stem cells into nervous system tissue; obtain primate embryonic stem cell, propagate in culture containing fibroblast growth factor, recover cells
04/10/2003US20030068817 Tubularized tissue; for use in the treatment of hypoxia, vascular necrosis, foot ulcer diabetes, athersclerosis, stroke, wounds and bone fractures
04/10/2003US20030068816 Mammalian cell culture broth for use in propagation of mammalian cells in vitro
04/10/2003US20030068812 Immune modulation device for use in animals
04/10/2003US20030068807 Precursor conversion screening methods
1 ... 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 ... 1827